Evangeline Diagnostic Center LLC

Evangeline Diagnostic Center LLC was paid $2.85M by Medicaid between Jan 2018 and Aug 2020, across 99 billing codes. Its largest line is G0481, Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed — 6.2% of everything it billed.

Compared with peers

Next to other Clinical Medical Laboratory providers in Louisiana

Rank by total paid#19 of 66

Median peer was paid$253K

This provider vs. median11×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	328,274	$1.87M
2019	191,371	$980K
2020	21	$1K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
G0481	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed	6.2%	2,526	1,115	$175K
80373		5.5%	15,845	5,731	$156K
80372		5.5%	15,837	5,730	$156K
80367		5.5%	15,823	5,719	$156K
80369		5.4%	15,389	5,477	$155K
80337		5.4%	14,689	5,290	$155K
80357		5.3%	15,821	5,696	$151K
80366		5.3%	15,796	5,690	$151K
80368		5.2%	15,633	5,545	$149K
80338		5.2%	15,420	5,446	$147K
80323		5.1%	15,416	5,516	$145K
80339		4.7%	15,809	5,698	$135K

87 more codes

80355		3.7%	15,277	$106K
80321		3.4%	15,119	$96K
80374		3.0%	9,041	$86K
84311		1.5%	11,732	$42K
80348		1.3%	16,137	$37K
80354		1.3%	16,160	$37K
80347		1.3%	14,932	$37K
80365		1.3%	16,142	$37K
80361		1.3%	16,151	$37K
80349		1.3%	16,077	$36K
80371		1.3%	15,947	$36K
80358		1.3%	16,170	$36K
80360		1.3%	15,962	$36K
80356		1.2%	15,969	$35K
80364		1.2%	15,729	$34K
80359		1.2%	15,985	$34K
83992		1.2%	15,727	$33K
80353		1.2%	16,143	$33K
80350		1.1%	12,976	$32K
80325		1.1%	14,809	$31K
80336		<1%	663	$6K
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	<1%	424	$6K
82670		<1%	380	$6K
84403		<1%	373	$5K
84144		<1%	376	$5K
82627		<1%	380	$5K
84443	Thyroid stimulating hormone (TSH)	<1%	391	$5K
84270		<1%	385	$4K
84146		<1%	378	$4K
84681		<1%	376	$4K
80370		<1%	254	$4K
83001		<1%	382	$4K
83002		<1%	381	$4K
82533		<1%	372	$3K
80362		<1%	330	$3K
82607		<1%	403	$3K
80346		<1%	1,596	$3K
80324		<1%	1,680	$3K
82728		<1%	400	$3K
80061	Lipid panel	<1%	430	$3K
83003		<1%	298	$3K
82746		<1%	342	$2K
83525		<1%	375	$2K
84439		<1%	373	$2K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	<1%	425	$2K
83090		<1%	238	$2K
84481		<1%	390	$2K
83036	Hemoglobin; glycosylated (A1C)	<1%	472	$2K
80048	Basic metabolic panel (calcium, ionized)	<1%	331	$2K
80076		<1%	362	$2K
83695		<1%	439	$2K
84402		<1%	120	$2K
83735		<1%	428	$2K
82150		<1%	432	$2K
84702		<1%	142	$1K
82570		<1%	12,173	$1K
83937		<1%	47	$1K
84153		<1%	157	$1K
86140		<1%	385	$1K
81025		<1%	277	$1K
84100		<1%	455	$998.03
83986		<1%	12,144	$979.00
83550		<1%	147	$862.29
80335		<1%	96	$738.00
82977		<1%	143	$687.36
83540		<1%	155	$411.18
80050	General health panel	<1%	13	$394.80
84550		<1%	151	$381.65
80332		<1%	17	$247.50
80069		<1%	26	$230.37
87804	Infectious agent antigen detection by immunoassay; Influenza, each type	<1%	13	$157.56
82248		<1%	47	$152.40
80053	Comprehensive metabolic panel	<1%	23	$150.41
G0483	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed	<1%	156	$148.20
84436		<1%	225	$134.68
84480		<1%	194	$51.04
82565		<1%	17	$40.72
82310		<1%	16	$35.91
84520		<1%	17	$31.44
82374		<1%	13	$24.30
84295		<1%	13	$24.00
84132		<1%	13	$22.85
82435		<1%	13	$22.85
84479		0%	50	$0.00
82172		0%	466	$0.00
82247		0%	50	$0.00
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	0%	244	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialWILKS, TERRY (OWNER/CEO)

Same official

Other billing entities under WILKS, TERRY

Full network →

Provider	Location	Paid
Acadian Diagnostic Laboratories LLC	Baton Rouge, LA	$6.81M

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.